|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
METHODS |
From the Office of Clinical Pharmacology, Office of Translational Science, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
The purpose of this study is to compare and evaluate logistic regression and time-to-event analysis, 2 commonly used methods for exposure–adverse event (AE) analyses. An AE data set selected from clinical trials is analyzed by both methods and the results are compared. The parameter estimates, odds ratios for logistic regression, and hazard ratios for time-to-event analysis for each AE are compared and further analyzed. In a data set involving 822 patients, 25 AEs are analyzed. A linear relationship is demonstrated between the parameter estimates from the 2 methods and between the odds ratios and hazard ratios. The small differences between the 2 analyses are related to the lower rate of the events and the weaker effects of the risk factors. Although the 2 methods can make predications for the risks, the severity, duration, and recurrence are not well defined. AE time profiles showing the onset, duration, and offset of AEs are important for risk assessment and management. Both analyses can provide information about exposure–AE relationship, and the results from the 2 analyses are consistent in most cases. One should not use the logistic model when length of follow-up varies because of biased estimates. The application of the 2 methods should be combined with AE profiling.
Key Words: Exposure-response adverse events logistic regression proportional hazard model time-to-event analysis
Address for reprints: John Z. Duan, PhD, Office of Clinical Pharmacology, CDER, FDA. HFD-860, Building 51, Room 2166, 10903 New Hampshire Avenue, Silver Spring, MD 20993; e-mail: john.duan{at}fda.hhs.gov.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
P. S. Nishtala, R. A. Fois, A. J. McLachlan, J. S. Bell, P. J. Kelly, and T. F. Chen Anticholinergic Activity of Commonly Prescribed Medications and Neuropsychiatric Adverse Events in Older People J. Clin. Pharmacol., October 1, 2009; 49(10): 1176 - 1184. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |